Harmony Biosciences Holdings (HRMY) Receivables - Net (2019 - 2026)
Harmony Biosciences Holdings' Receivables - Net came in at $111 million for Q2 2026, up 19.4% from $92.98 million a year earlier and up 2.6% from the prior quarter.
Powered by 
Analysis
Harmony Biosciences Holdings (HRMY) Receivables - Net (2019 - 2026) Analysis & Trends
At the end of FY2025, Harmony Biosciences Holdings' Receivables - Net was $96.79 million, up 16.6% from FY2024.
- Receivables - Net has increased in each of the last six years, with a five-year compound annual growth rate of 34.3% (FY2020 to FY2025).
- Going back by year, Receivables - Net was $83.03 million in FY2024 (+12.0%), $74.14 million in FY2023 (+35.4%), $54.74 million in FY2022 (+57.1%) and $34.84 million in FY2021 (+57.1%).
- The Q2 2026 figure represents the highest quarterly Receivables - Net in data going back to Q4 2019.
- Year-over-year, Receivables - Net has increased for 20 consecutive quarters, with growth averaging 17.4% over the last eight quarters.
- The year-over-year growth in Receivables - Net has ranged between 2.1% (Q1 2026) and 103.4% (Q3 2021) over the last five years.
- Business Quant data shows HRMY's Receivables - Net at $108.22 million (Q1 2026), $96.79 million (Q4 2025) and $100.65 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn |
| 10 | Harmony Biosciences Holdings | 2.33 Bn | -431.22 Mn | 198.08 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 111.00 Mn |
| Mar 31, 2026 | 108.22 Mn |
| Dec 31, 2025 | 96.79 Mn |
| Sep 30, 2025 | 100.65 Mn |
| Jun 30, 2025 | 92.98 Mn |
| Mar 31, 2025 | 105.97 Mn |
| Dec 31, 2024 | 83.03 Mn |
| Sep 30, 2024 | 81.50 Mn |
| Jun 30, 2024 | 83.16 Mn |
| Mar 31, 2024 | 79.72 Mn |
| Dec 31, 2023 | 74.14 Mn |
| Sep 30, 2023 | 67.26 Mn |
| Jun 30, 2023 | 63.81 Mn |
| Mar 31, 2023 | 52.58 Mn |
| Dec 31, 2022 | 54.74 Mn |
| Sep 30, 2022 | 55.07 Mn |
| Jun 30, 2022 | 49.82 Mn |
| Mar 31, 2022 | 38.13 Mn |
| Dec 31, 2021 | 34.84 Mn |
| Sep 30, 2021 | 33.21 Mn |
API Access
Harmony Biosciences Holdings Receivables - Net API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=receivables-net&ticker=HRMY&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "receivables-net", "ticker": "HRMY", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=receivables-net&ticker=HRMY&period=max&api_key=YOUR_API_KEY");
const data = await res.json();